» Articles » PMID: 27940056

Terpenoids As Anti-colon Cancer Agents - A Comprehensive Review on Its Mechanistic Perspectives

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2016 Dec 13
PMID 27940056
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Multistep model of colon carcinogenesis has provided the framework to advance our understanding of the molecular basis of colon cancer. This multistage process of carcinogenesis takes a long period to transform from a normal epithelial cell to invasive carcinoma. Thus, it provides enough time to intervene the process of carcinogenesis especially through dietary modification. In spite of the in-depth understanding of the colon cancer etiology and pathophysiology and its association with diet, colon cancer remains a major cause of cancer mortality worldwide. Phytochemicals and their derivatives are gaining attention in cancer prevention and treatment strategies because of cancer chemotherapy associated adverse effects. Being the largest group of phytochemicals traditionally used for medicinal purpose in India and China, terpenoids are recently being explored as anticancer agents. Anticancer properties of terpenoids are associated with various mechanisms like counteraction of oxidative stress, potentiating endogenous antioxidants, improving detoxification potential, disrupting cell survival pathways and inducing apoptosis. This review gives a comprehensive idea of naturally occurring terpenoids as useful agents for the prevention of colon cancer with reference to their classes, sources and molecular targets. Based on the explored molecular targets further research in colon cancer chemoprevention is warranted.

Citing Articles

Essential oils from Lamiaceae plants effectively control Colletotrichum gloeosporioides, Elsinoë ampelina and Phytophthora infestans.

Horst M, Santos L, Knob A, Silva E, Faria C Braz J Microbiol. 2025; .

PMID: 39932661 DOI: 10.1007/s42770-024-01607-4.


Inhibitory Effects of the Polyphenols from the Root of Blume on Fatty Acid Synthase Activity and Human Colon Cancer Cells.

Liang Y, Ban Y, Liu L, Li Y Molecules. 2024; 29(5).

PMID: 38474695 PMC: 10934235. DOI: 10.3390/molecules29051180.


Bornyl acetate extracted from Sharen () inhibits proliferation, invasion and induces apoptosis by suppressing phosphatidylinositol-3-kinase/protein kinase B signaling in colorectal cancer.

Xiaohua L, Zhihang D, Jianjun Y, Yongyu Z, Yihang L, Shifang L J Tradit Chin Med. 2023; 43(6):1081-1091.

PMID: 37946470 PMC: 10623251. DOI: 10.19852/j.cnki.jtcm.20231018.002.


Anticancer effect of terpenes: focus on malignant melanoma.

Wroblewska-Luczka P, Cabaj J, Bargiel J, Luszczki J Pharmacol Rep. 2023; 75(5):1115-1125.

PMID: 37515699 PMC: 10539410. DOI: 10.1007/s43440-023-00512-1.


Medicinal Characteristics of L. in Colorectal Cancer Management.

Macharia J, Kaposztas Z, Bence R Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513827 PMC: 10384768. DOI: 10.3390/ph16070915.